ConductScience.org, home

Paper31344409

Ursodeoxycholic acid inhibits ENaC and Na/K pump activity to restore airway surface liquid height in cystic fibrosis bronchial epithelial cells.

Mroz MS and 1 other. Steroids, 2019. Cited by 16 papers, by iCite.

Cite this record

ConductScience Library. Ursodeoxycholic acid inhibits ENaC and Na/K pump activity to restore airway surface liquid height in cystic fibrosis bronchial epithelial cells. Papers, record 31344409. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/31344409

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Ursodeoxycholic acid inhibits ENaC and Na/K pump activity to restore airway surface liquid height in cystic fibrosis bronchial epithelial cells.
PubMed
Journal
Steroids
PubMed
Year
2019
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
16
iCite
Relative citation ratio, by iCite
0.83
iCite
Revised in PubMed
2020-05-13
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Mroz MSMagdalena S
2Harvey BJBrian J

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
BronchiMajor topic
Cystic FibrosisMajor topic
Epithelial CellsMajor topic
Epithelial Sodium ChannelsMajor topic
Sodium-Potassium-Exchanging ATPaseMajor topic
Ursodeoxycholic AcidMajor topic
Cell Line
Cystic Fibrosis Transmembrane Conductance Regulator
Electrophysiological Phenomena
Epithelial Sodium Channel Blockers
Gene Expression Regulation, Enzymologic
Humans
Phenotype
Surface Properties

Source PubMed

Download CSV of topics

Cited by13

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 16 citations.

PMIDTitleJournalYearIn PapersSource
42939751Bile Acids and Their Receptors in Respiratory Diseases: Mechanistic and Therapeutic Perspectives.Biomolecules2026https://conductscience.org/library/papers/42939751PubMed
41239347Construction and application of a risk prediction model for sputum viscosity in patients with laryngeal malignant tumors after operation.BMC Surg2025https://conductscience.org/library/papers/41239347PubMed
41102022Ursodeoxycholic Acid Attenuates B Cell Susceptibility to SARS-CoV-2 Spike Protein by Interfering Its Binding to ACE2.Biomol Ther (Seoul)2025https://conductscience.org/library/papers/41102022PubMed
40115259Ursodeoxycholic and chenodeoxycholic bile acids alleviate endotoxininduced acute lung injury in rats by modulating aquaporin expression and pathways associated with apoptosis and inflammation.Front Pharmacol2025https://conductscience.org/library/papers/40115259PubMed
39109974Epithelial Na + Channels Function as Extracellular Sensors.Compr Physiol2024https://conductscience.org/library/papers/39109974PubMed
39026347Sex differences in airway disease: estrogen and airway surface liquid dynamics.Biol Sex Differ2024https://conductscience.org/library/papers/39026347PubMed
35658221Ursodeoxycholic acid ameliorates cell migration retarded by the SARS-CoV-2 spike protein in BEAS-2B human bronchial epithelial cells.Biomed Pharmacother2022https://conductscience.org/library/papers/35658221PubMed
35462606Downregulation of epithelial sodium channel (ENaC) activity in cystic fibrosis cells by epigenetic targeting.Cell Mol Life Sci2022https://conductscience.org/library/papers/35462606PubMed
35245132Bile acids and salt-sensitive hypertension: a role of the gut-liver axis.Am J Physiol Heart Circ Physiol2022https://conductscience.org/library/papers/35245132PubMed
34755536Contributions of bile acids to gastrointestinal physiology as receptor agonists and modifiers of ion channels.Am J Physiol Gastrointest Liver Physiol2022https://conductscience.org/library/papers/34755536PubMed
34680554Dysfunction in the Cystic Fibrosis Transmembrane Regulator in Chronic Obstructive Pulmonary Disease as a Potential Target for Personalised Medicine.Biomedicines2021https://conductscience.org/library/papers/34680554PubMed
34276407Nitric Oxide System and Bronchial Epithelium: More Than a Barrier.Front Physiol2021https://conductscience.org/library/papers/34276407PubMed
33916525DNA Methylation Patterns Correlate with the Expression of SCNN1A, SCNN1B, and SCNN1G (Epithelial Sodium Channel, ENaC) Genes.Int J Mol Sci2021https://conductscience.org/library/papers/33916525PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
CFTR1080PubTator's text mininghttps://conductscience.org/library/genes/1080

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/31344409

GET https://conductscience.org/api/papers/v1/31344409/authors